Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.62 |
| ▸ | MAG | P20916 | 10/20 | 0.61 |
| ▸ | SELL | P14151 | 1/20 | 0.52 |
| ▸ | SELP | P16109 | 1/20 | 0.52 |
| ▸ | SELE | P16581 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28957979 | 1.00 | SIGLEC7 (0.62) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL21570085 | 1.00 | SIGLEC7 (0.62) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL28957980 | 1.00 | SIGLEC7 (0.62) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL29364999 | 1.00 | SIGLEC7 (0.62) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL23857822 | 0.97 | MAG (0.62) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL29361397 | 0.97 | MAG (0.62) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL29449201 | 0.95 | SIGLEC7 (0.66) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL28100889 | 0.93 | MAG (0.59) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL29809799 | 0.92 | SIGLEC7 (0.63) | SIGLEC7MAGSELLSELPSELE | |
| SCHEMBL29790139 | 0.92 | SIGLEC7 (0.63) | SIGLEC7MAGSELLSELPSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3620510-B2 | FERMENTATIVE PRODUCTION OF OLIGOSACCHARIDES BY TOTAL FERMENTATION UTILIZING A MIXED FEEDSTOCK | CHR HANSEN HMO GMBH (DE) | 2026-05-27 | — | — | EP | claimed |
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | INBIOSE N V (BE) | 2026-05-21 | — | — | US | claimed |
| EP-4719432-A1 | COMBINATION OF VITAMINS AND OLIGOSACCHARIDES FOR ENHANCING BONE GROWTH AND/OR BONE STRENGTH | Société des Produits Nestlé S.A. (CH) | 2026-04-08 | — | — | EP | claimed |
| EP-4719431-A1 | PREBIOTICS FOR TREATING AND/OR PREVENTING VITAMIN K2 DEFICIENCY | Société des Produits Nestlé S.A. (CH) | 2026-04-08 | — | — | EP | claimed |
| EP-4719433-A1 | COMBINATION OF VITAMINS, 2'-FUCOSYLLACTOSE AND A PROBIOTIC FOR ENHANCING BONE GROWTH AND/OR BONE STRENGTH | Société des Produits Nestlé S.A. (CH) | 2026-04-08 | — | — | EP | claimed |
| US-20260062726-A1 | HYBRID METHOD FOR PRODUCING COMPLEX HMOS | DSM IP ASSETS BV (NL) | 2026-03-05 | — | — | US | claimed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| EP-4686760-A1 | SIALYLTRANSFERASES FOR THE SYNTHESIS OF SIALYLATED GLYCANS, GLYCOCONJUGATES AND GLYCOPROTEINS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-02-04 | — | — | EP | claimed |
| EP-4661697-A1 | NUTRITIONAL COMPOSITION WITH IMPROVED SEGREGATION RESISTANCE | N.V. Nutricia (NL) | 2025-12-17 | — | — | EP | claimed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| EP-4038178-A1 | NUTRIENT COMPOSITIONS AND METHODS, KITS, AND CELL COMPOSITIONS FOR PRODUCING THE SAME | Turtletree Lab Pte. Ltd. (SG) | 2022-08-10 | — | — | EP | claimed |
| WO-2022157280-A1 | NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN PRODUCTION OF SIALYLATED HMOS | GLYCOM A/S (DK) | 2022-07-28 | — | — | WO | claimed |
| CN-111382535-B | Finite element model design method for automobile collision honeycomb barrier | 上海中氐实业股份有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114787343-A | Nutritional compositions and methods, kits and cell compositions for producing the same | 龟树实验室私人有限公司 | 2022-07-22 | — | — | CN | claimed |
| WO-2022119982-A2 | MODULAR GLYCAN PRODUCTION WITH IMMOBILIZED BIONANOCATALYSTS | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2022-06-09 | — | — | WO | claimed |
| CN-114594169-A | Quantitative detection method for oligosaccharide content in breast milk | 中国科学院大连化学物理研究所 | 2022-06-07 | — | — | CN | claimed |
| CN-114555780-A | Production of a biological product in a host cell | 因比奥斯公司 | 2022-05-27 | — | — | CN | claimed |
| US-20220064686-A1 | USE OF SUBSTRATE IMPORTERS FOR THE EXPORT OF OLIGOSACCHARIDES | GINKGO BIOWORKS, INC | 2022-03-03 | — | — | US | claimed |
| CN-112163363-B | Finite element model design method for collision honeycomb barrier bonding colloid | 上海中氐实业股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-112841317-B | Nutritional composition suitable for infants fed by elderly puerperae | 合生元（广州）健康产品有限公司 | 2022-02-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062726-A1 | HYBRID METHOD FOR PRODUCING COMPLEX HMOS | FUCA1, GMDS, MANBA | SIGLEC7 474/4885MAG 2423/4885SELL 2472/4885 |
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | GALNT3, NANS, ENGASE | SIGLEC7 512/4885MAG 1618/4885SELL 599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.